Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure?
نویسندگان
چکیده
منابع مشابه
Beta-adrenergic receptor antagonists and chronic heart failure in children
Chronic congestive heart failure (HF) occurs in infants and children as a result of systemic ventricle incompetence. Neurohormonal activation is thought to be the main consequence of cardiac pump failure and cause of further worsening. Several large multicenter randomized trials have demonstrated that beta-adrenergic blocking agents can improve ventricular ejection fraction, symptoms, and survi...
متن کاملAngiotensin Receptor Antagonists to Prevent Sudden Death in Heart Failure: Does the Dose Matter?
International guidelines recommend ICD implantation in patients with severe left ventricular dysfunction of any origin only after careful optimization of medical therapy. Indeed, major randomized clinical trials suggest that suboptimal use of fundamental drugs, such as ACE inhibitors (ACE-i) and beta-blockers, may affect ICD shock-free survival, sudden cardiac death (SCD), and overall mortality...
متن کاملSympathetic cerebral vasoconstriction blocked by adrenergic alpha receptor antagonists.
s . 240 from the American Heart Association 265 Report of the Joint Committee for Stroke Facilities— VI I . Medical and Surgical Management of Stroke 269
متن کاملVasopressin receptor antagonists in heart failure.
Vasopressin receptor antagonists are a new class of drugs that address the problems of fluid retention, hyponatremia, and renal dysfunction in heart failure. Elevated vasopressin levels in heart failure cause myocardial fibrosis, hypertrophy and vasoconstriction by activating the V1a receptors, as well as water retention and hyponatremia by activating V2 receptors. Antagonism of V1a receptors a...
متن کاملArginine Vasopressin Receptor Antagonists for Heart Failure
eart failure (HF) is among the most common causes of ospitalization, and its incidence will likely increase in an ging population of “survivors” (1). Pharmacological treatent targeted at neurohormonal activation has improved urvival, but mortality remains substantial in patients with F, thus warranting the search for novel therapeutic aproaches. Novel agents under investigation for the treatent...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Heart Failure
سال: 2018
ISSN: 2213-1779
DOI: 10.1016/j.jchf.2018.07.013